Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1987 Jan;31(1):134. doi: 10.1128/aac.31.1.134

Rifabutin and rifapentine compared with rifampin against Mycobacterium leprae in mice.

S R Pattyn
PMCID: PMC174672  PMID: 3032088

Full text

PDF

Page 134

134

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Assandri A., Cristina T., Moro L. Physiological disposition of a series of rifamycins in rat: a comparative study. J Antibiot (Tokyo) 1978 Sep;31(9):894–901. doi: 10.7164/antibiotics.31.894. [DOI] [PubMed] [Google Scholar]
  2. Cynamon M. H. Comparative in vitro activities of MDL 473, rifampin, and ansamycin against Mycobacterium intracellulare. Antimicrob Agents Chemother. 1985 Sep;28(3):440–441. doi: 10.1128/aac.28.3.440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Hastings R. C., Jacobson R. R. Activity of ansamycin against Mycobacterium leprae in mice. Lancet. 1983 Nov 5;2(8358):1079–1080. doi: 10.1016/s0140-6736(83)91060-7. [DOI] [PubMed] [Google Scholar]
  4. Pattyn S. R. A comparison of the bactericidal activity of a series of rifampicins against Mycobacterium leprae. Arzneimittelforschung. 1982;32(1):15–17. [PubMed] [Google Scholar]
  5. Pattyn S. R., Saerens E. J. Activity of three new rifamycin derivates on the experimental infection by Mycobacterium leprae. Ann Soc Belg Med Trop. 1977;57(3):169–173. [PubMed] [Google Scholar]
  6. Sanfilippo A., Della Bruna C., Marsili L., Morvillo E., Pasqualucci C. R., Schioppacassi G., Ungheri D. Biological activity of a new class of rifamycins. Spiro-piperidyl-rifamycins. J Antibiot (Tokyo) 1980 Oct;33(10):1193–1198. doi: 10.7164/antibiotics.33.1193. [DOI] [PubMed] [Google Scholar]
  7. Shepard C. C., Levy L., Fasal P. Rapid bactericidal effect of rifampin on Mycobacterium leprae. Am J Trop Med Hyg. 1972 Jul;21(4):446–449. doi: 10.4269/ajtmh.1972.21.446. [DOI] [PubMed] [Google Scholar]
  8. Truffot-Pernot C., Grosset J., Bismuth R., Lecoeur H. Activité de la rifampicine administrée de manière intermittente et de la cyclopentyl rifamycine (ou DL473) sur la tuberculose expérimentale de la souris. Rev Fr Mal Respir. 1983;11(6):875–882. [PubMed] [Google Scholar]
  9. Woodley C. L., Kilburn J. O. In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiro-piperidyl rifamycin. Am Rev Respir Dis. 1982 Sep;126(3):586–587. doi: 10.1164/arrd.1982.126.3.586. [DOI] [PubMed] [Google Scholar]
  10. Yates M. D., Collins C. H. Comparison of the sensitivity of mycobacteria to the cyclopentyl rifamycin DL473 and rifampicin. J Antimicrob Chemother. 1982 Aug;10(2):147–150. doi: 10.1093/jac/10.2.147. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES